百时美施贵宝

Manufacturing biologics and cell therapies is a complex process. Take a look at our Devens, Massachusetts facility, which supports process development, clinical manufacturing and commercial manufacturing for these medicines. Spanning 89 acres and 1,700 employees, Devens is critical in helping deliver on our vision of transforming patients’ lives through science. Learn more about how BMS has become a leading life sciences presence in Massachusetts. https://bit.ly/3Z15qhF #OneBMS

Digital health technology and AI are creating a step change in the way patients are diagnosed and monitored for serious diseases. In line with this progress, we are thrilled to congratulate Viz.AI on receiving the Prix Galien USA 2024 Award for Best Digital Health Solution for their incredible Viz HCM? module. ? As always, we keep patients at the heart of everything we do. By continuing to explore and leverage digital health technologies, we remain committed to redefining what’s possible for patients now and in the future. #OneBMS

Learn more about hypertrophic cardiomyopathy by visiting Inside the Science to register and access medical videos and other educational resources. https://bit.ly/4i21oOM #AHA2024

We’re honored to share that Greg Meyers, EVP, Chief Digital & Technology Officer has been named to Forbes’ 2024 CIO Next List. As AI and machine learning continue to transform the future of healthcare, Greg has been instrumental in steering how our company leverages these advanced technologies to accelerate our scientific pursuits, empower our employees to do their best work, and deliver for our patients around the world. https://bit.ly/491C47y #OneBMS

We are committed to advancing research in cardiovascular diseases. Learn more about our ongoing trials in hypertrophic cardiomyopathy and other cardiovascular conditions on our website, BMS Clinical Trials. https://bit.ly/4fW39v0

We recently hosted an important discussion about breaking down barriers to healthcare access in low- and middle-income countries, known as LMICs. Together with the Union for International Cancer Control (UICC)’s ATOM Coalition and The Max Foundation, we’re focused on finding sustainable solutions, such as with the ASPIRE initiative, to ensure that every patient gets the care they need. #HealthEquity #GlobalHealth

This BMS Veteran and Military Appreciation Month, our Veterans Community Network (VCN) People & Business Resource Group (PBRG) hosted a Veterans Salute and fireside chat with U.S. Marine Sergeant Carlos Evans, his wife, Rosemarie, a nurse and advocate, and Samit Hirawat (he/him), Chief Medical Officer and Head of Development. See highlights from the event—held in partnership with our Disability Advancement Workplace Network and Organization for Latino Achievement PBRGs—and join us in celebrating the history and contributions of those who’ve served. Learn about VCN Global Lead, Ricardo Sanchez and how our VCN community promotes the success of veteran service members: https://bit.ly/4eCH3wJ #OneBMS

We are committed to advancing care for the Rheumatology community. Learn more about our ongoing clinical trials in lupus and Sjogren's disease, and other rheumatologic conditions at BMS Clinical Trials. https://bit.ly/3UUqbdW #OneBMS

We’re looking forward to presenting new data at the American Society of Hematology Annual Meeting and Exposition alongside thousands of healthcare professionals, researchers, industry peers and advocacy partners. Learn more about across our key research platforms, cell therapy and targeted protein degradation, at #ASH24: https://bit.ly/3Zei7Hx

Review the data and gain real-world insights from 22 months of a symptomatic obstructive HCM treatment in >6000 adult patients from our risk evaluation and mitigation strategy program. https://bit.ly/4eAKYtN #AHA2024